Variant report
Variant | nsv971662 |
---|---|
Chromosome Location | chr8:68493011-68494892 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:68487277..68489149-chr8:68492543..68494936,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141803986 | chr8:68493026-68493027 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187022481 | chr8:68493074-68493075 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs62513792 | chr8:68493110-68493111 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113610316 | chr8:68493133-68493134 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs78078228 | chr8:68493215-68493216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs191458161 | chr8:68493219-68493220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549130424 | chr8:68493224-68493225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10091234 | chr8:68493236-68493237 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs547936567 | chr8:68493250-68493251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537174922 | chr8:68493259-68493260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs116849771 | chr8:68493304-68493305 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs55883952 | chr8:68493309-68493310 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs539401498 | chr8:68493310-68493311 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553308326 | chr8:68493340-68493341 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs560563133 | chr8:68493364-68493365 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs74540427 | chr8:68493424-68493425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114489946 | chr8:68493453-68493454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs111584709 | chr8:68493480-68493481 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs368629070 | chr8:68493496-68493497 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544740023 | chr8:68493530-68493531 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181201129 | chr8:68493588-68493589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577972237 | chr8:68493605-68493606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs540205469 | chr8:68493631-68493632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs201876747 | chr8:68493632-68493633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529575336 | chr8:68493664-68493665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549242572 | chr8:68493712-68493713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs563141032 | chr8:68493713-68493714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs57095373 | chr8:68493719-68493720 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs550662375 | chr8:68493763-68493764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570408702 | chr8:68493776-68493777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs185305924 | chr8:68493851-68493852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs547024479 | chr8:68493876-68493877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs566460911 | chr8:68493907-68493908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149478066 | chr8:68493933-68493934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs535776038 | chr8:68493942-68493943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555372121 | chr8:68493947-68493948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs568519437 | chr8:68493950-68493951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139590782 | chr8:68493953-68493954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs900899 | chr8:68493987-68493988 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs377586843 | chr8:68493997-68493998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558251789 | chr8:68494021-68494022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189872447 | chr8:68494111-68494112 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529446566 | chr8:68494121-68494122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553775623 | chr8:68494165-68494166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs573693797 | chr8:68494286-68494287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557495287 | chr8:68494289-68494290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs543344632 | chr8:68494294-68494295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs112699717 | chr8:68494417-68494418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs448546 | chr8:68494426-68494427 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs545247484 | chr8:68494447-68494448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
head and neck squamous cell carcinoma | 16715129 | CNVD |
Prostate cancer | 16461572 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:68490600-68493400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
2 | chr8:68491400-68493400 | Enhancers | Primary T cells fromperipheralblood | blood |
3 | chr8:68491800-68493200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr8:68491800-68493200 | Enhancers | Primary T helper cells fromperipheralblood | blood |
5 | chr8:68492000-68493200 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
6 | chr8:68492000-68493200 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
7 | chr8:68492000-68493200 | Enhancers | Primary T regulatory cells fromperipheralblood | blood |
8 | chr8:68492200-68493200 | Enhancers | Primary T cells from cord blood | blood |
9 | chr8:68492200-68493200 | Enhancers | Primary T helper naive cells from peripheral blood | blood |
10 | chr8:68492200-68493400 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
11 | chr8:68492400-68493200 | Enhancers | GM12878-XiMat | blood |
12 | chr8:68492400-68493600 | Enhancers | Dnd41 | blood |
13 | chr8:68492600-68494400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr8:68492800-68493200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr8:68493400-68494000 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
16 | chr8:68494000-68494200 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
17 | chr8:68494400-68495000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |